EASYGEN is led by Fresenius and academically co-led by Fraunhofer Institute, IZI, Leipzig - one of Europe's foremost ...

BaseCamp is the first genetic medicine manufacturing business to receive certification across viral gene delivery, non-viral gene delivery, and cell therapy products WALTHAM, Mass., Aug. 13, 2025 ...

As transformative as they may be for patients, cell and gene therapies are creating new kinds of uncertainty and challenges ...

Q2 2025 Management View Joseph Michael Burnett, CEO, described 2025 as the start of ClearPoint Neuro’s “third phase,” called Fast. Forward., emphasizing an expanded commitment to cell and gene therapy ...

Fresenius SE & Co. KGaA is leading an 8 million euro EU-backed effort to make CAR-T cell therapy faster, more affordable, and more accessible to ...

Aiming to Commercialize Industry-first Continuous Electroporation TechnologyTOKYO and KYOTO, August 14, 2025 -- FUJIFILM ...

Bharat currently has five products in its personalized medicine pipeline—two in cell culture and three in the gene therapy segment, the Hindu Business Line reported late last week, citing ...

Uniphar, a global leader in pharmaceutical and medtech solutions has announced the launch of its 10th cell and gene therapy (CGT) project. The milestone reinforces Uniphar’s commitment to ...

The 2024 annual review of the Cell and Gene Therapy Catapult highlighted that the UK remains an important market for developing and marketing new CGT. 7 Recently, several new CGTs have been ...

As Foroohar put it, Marks “was a driver of a lot of acceleration” for the cell and gene therapy space. Now, with Marks’ departure—plus a massive workforce reduction at the FDA—that ...